IP Library Granted Patent US 11,918,244
Granted Patent B2
US 11,918,244 · App. 18/351,307 · Granted Mar 5, 2024

Intravascular treatment of vascular occlusion and associated devices, systems, and methods

Inventors: Phil Marchand (Lake Forest, CA); John C. Thress (Capistrano Beach, CA); Jacob F. Louw (Carlsbad, CA); Brian J. Cox (Laguna Nigel, CA); Richard Quick (Mission Viejo, CA)
Assignee: Inari Medical, Inc.
A61B17/221A61B17/320725A61B17/3415A61B2017/00526A61B2017/22094A61B2017/2212
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,918,244
App. No.
18/351,307
Granted
Mar 5, 2024
Kind
B2
Abstract

Systems and methods for removal of thrombus from a blood vessel in a body of a patient are disclosed herein. The method can include: providing a thrombus extraction device including a proximal self-expanding member formed of a unitary fenestrated structure, a distal substantially cylindrical portion formed of a net-like filament mesh structure, and an inner shaft member connected to a distal end of the net-like filament mesh structure; advancing a catheter constraining the thrombus extraction device through a vascular thrombus, deploying the thrombus extraction; retracting the thrombus extraction device to separate a portion of the thrombus from the vessel wall and to capture the portion of the thrombus within the net-like filament mesh structure; and withdrawing the thrombus extraction device from the body to remove thrombus from the patient.

Claims (49)

1. A clot treatment assembly, comprising:

a first elongate shaft defining a lumen and having a distal portion a proximal portion;

a funnel coupled to the distal portion of the first elongate shaft;

a hub coupled to the proximal portion of the first elongate shaft;

an aspiration source;

a fluid path extending from the distal portion of the first elongate shaft, through the lumen of the elongate shaft, through the hub, and to the aspiration source; and

a second elongate shaft coaxial with the first elongate shaft, wherein—

the second elongate shaft includes a distal portion and a proximal portion,

the proximal portion is positioned at least partially within the hub,

the second elongate shaft is axially movable relative to the first elongate shaft between a first position and a second position,

in the first position, the distal portion of the second elongate shaft extends over the funnel to radially constrain the funnel in a constrained configuration, and

in the second position, the funnel is unconstrained by the distal portion of the second elongate shaft and configured to self-expand to an expanded configuration.

2. The clot treatment assembly of claim 1 wherein the hub includes a seal configured to seal the lumen of the first elongate shaft.

3. The clot treatment assembly of claim 1 wherein the hub includes a self-sealing seal configured to seal the lumen of the first elongate shaft.

4. The clot treatment assembly of claim 1 wherein the hub comprises a stop portion configured to inhibit further movement of the second elongate shaft past the second position.

5. The clot treatment assembly of claim 1 wherein the hub is shaped and sized to inhibit further movement of the second elongate shaft past the second position.

6. The clot treatment assembly of claim 1 , further comprising a valve along the fluid path between the aspiration source and the lumen of the first elongate shaft, wherein the valve is configured to control application of vacuum pressure generated by the aspiration source to the lumen of the elongate shaft.

7. The clot treatment assembly of claim 6 wherein the valve is user actuatable.

8. The clot treatment assembly of claim 1 , further comprising a user-actuatable valve along the fluid path between the aspiration source and the lumen of the first elongate shaft, wherein the user-actuatable valve is movable between (a) a closed position in which the aspiration source is fluidly disconnected from the lumen of the first elongate shaft and (b) an open position in which the aspiration source is fluidly connected to the lumen of the first elongate shaft.

9. The clot treatment assembly of claim 1 wherein the proximal portion of the first elongate shaft is fixedly coupled to the hub, and wherein the second elongate shaft is axially movable relative to the hub.

10. The clot treatment assembly of claim 1 wherein the funnel extends distally from the distal portion of the first elongate shaft.

11. The clot treatment assembly of claim 1 wherein the funnel has a conical shape in the expanded configuration.

12. The clot treatment assembly of claim 1 wherein the funnel extends distally from the distal portion of the first elongate shaft, wherein the funnel has a conical shape in the expanded configuration, and wherein the funnel has a minimum diameter at the distal portion of the first elongate shaft in the expanded configuration.

13. The clot treatment assembly of claim 1 wherein the funnel includes a laser cut metal structure defining a plurality of pores.

14. The clot treatment assembly of claim 1 wherein the funnel includes a laser cut nitinol structure defining a plurality of pores.

15. The clot treatment assembly of claim 1 wherein the funnel includes a laser cut tube.

16. The clot treatment assembly of claim 1 wherein the funnel is impermeable to blood.

17. A clot treatment assembly, comprising:

a first elongate shaft defining a lumen and having a distal portion a proximal portion;

a funnel coupled to the distal portion of the first elongate shaft;

a hub fixedly coupled to the proximal portion of the first elongate shaft, wherein the hub includes a stop portion;

an aspiration source;

a fluid path extending from the distal portion of the first elongate shaft, through the lumen of the elongate shaft, through the hub, and to the aspiration source; and

a second elongate shaft coaxial with the first elongate shaft, wherein—

the second elongate shaft includes a distal portion and a proximal portion,

the second elongate shaft is axially movable relative to the first elongate shaft in a single direction between a first position and a second position,

the stop portion of the hub is configured to inhibit further movement of the second elongate shaft in the single direction past the second position,

in the first position, the distal portion of the second elongate shaft extends over the funnel to radially constrain the funnel in a constrained configuration, and

in the second position, the funnel is unconstrained by the distal portion of the second elongate shaft and configured to self-expand to an expanded configuration.

18. The clot treatment assembly of claim 17 , further comprising a user-actuatable valve along the fluid path between the aspiration source and the lumen of the first elongate shaft, wherein—

the user-actuatable valve is movable between (a) a closed position in which the aspiration source is fluidly disconnected from the lumen of the first elongate shaft and (b) an open position in which the aspiration source is fluidly connected to the lumen of the first elongate shaft,

the proximal portion of the first elongate shaft is fixedly coupled to the hub,

the second elongate shaft is axially movable relative to the hub, and

the hub includes a seal configured to seal the lumen of the first elongate shaft.

19. The clot treatment assembly of claim 17 wherein—

the funnel includes a laser cut metal structure defining a plurality of pores,

the funnel extends distally from the distal portion of the first elongate shaft, and

the funnel has a conical shape in the expanded configuration.

20. The clot treatment assembly of claim 1 wherein the hub includes a seal configured to seal the lumen of the first elongate shaft.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Apr 29, 2026
From: INARI MEDICAL, INC.
To: STRYKER CORPORATION
Reel/Frame 075486/0805 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2023
From: MARCHAND, PHIL; THRESS, JOHN C.; LOUW, JACOB F.; COX, BRIAN J.; QUICK, RICHARD
To: INARI MEDICAL, INC.
Reel/Frame 065163/0568 →
Continuity (6)
Continuation 17362800 · Jun 29, 2021
Continuation 16425017 · May 29, 2019
Division 15268406 · Sep 16, 2016
Continuation 15268296 · Sep 16, 2016
Provisional Application 62245935 · Oct 23, 2015
Related Publication 20230355259A1 · Nov 9, 2023
Cited By (14)
US 12,239,333 US 12,251,120 US 12,274,459 US 12,285,182 US 12,310,608 US 12,343,028 US 12,364,496 US 12,465,382 US 12,478,390 US 12,496,081 US 12,558,112 US 12,558,486 US 12,685,549 US 12,702,538